Skip to main content
. 2024 Jan 25;15(3):e00683. doi: 10.14309/ctg.0000000000000683

Table 4.

ORs of SSADR according to patient, procedure, and physician characteristics by all years, 2010 and 2020

Characteristics All yearsa 2010b 2020c P-interactiond
OR (95% CI) OR (95% CI) OR (95% CI)
Patient-related
 Age
  <50 yr Reference Reference Reference 0.30
  50–75 yr 0.82 (0.77–0.88) 1.69 (0.58–4.93) 0.75 (0.64–0.86)
  >75 yr 0.80 (0.73–0.88) 1.84 (0.22–15.40) 0.54 (0.44–0.66)
 Sex
  Male Reference Reference Reference 0.41
  Female 1.21 (1.17–1.26) 0.99 (0.68–1.44) 1.16 (1.04–1.29)
 BMI
  <25 kg/m2 Reference Reference Reference 0.98
  25–30 kg/m2 1.04 (0.98–1.10) 0.99 (0.42–2.35) 0.92 (0.80–1.05)
  >30 kg/m2 0.99 (0.91–1.08) 0.97 (0.43–2.19) 0.93 (0.77–1.11)
  Unknown 1.49 (1.33–1.66) 2.41 (1.39–4.17) 0.93 (0.78–1.11)
 Race
  White Reference Reference Reference 0.88
  Asian 0.59 (0.54–0.65) 0.63 (0.39–1.00) 0.57 (0.48–0.68)
  African American 0.43 (0.36–0.51) 0.41 (0.06–3.06) 0.38 (0.22–0.65)
  Other 0.57 (0.49–0.66) 0.42 (0.09–1.90) 0.62 (0.52–0.75)
  Unknown 0.74 (0.67–0.81) 0.47 (0.15–1.46) 0.74 (0.59–0.92)
 Smoking status
  Never smoker Reference Reference Reference 0.40
  Current smoker 1.06 (0.97–1.15) 0.58 (0.11–3.10) 1.19 (0.92–1.54)
  Former smoker 0.95 (0.89–1.00) 1.02 (0.52–2.01) 0.92 (0.80–1.05)
  Unknown 0.94 (0.87–1.01) 0.40 (0.27–0.58) 1.10 (0.95–1.28)
 Charlson comorbidity
  0 Reference Reference Reference 0.13
  1 0.92 (0.88–0.95) 1.34 (0.74–2.40) 0.76 (0.67–0.87)
  ≥2 0.85 (0.82–0.88) 1.26 (0.70–2.26) 0.80 (0.70–0.91)
 Colonoscopy indication
  Average risk Reference Reference Reference 0.18
  High risk 0.90 (0.85–0.96) 1.63 (0.75–3.51) 0.96 (0.88–1.05)
Procedure-related
 Mucosal assist device
  No Reference Reference Reference NAe
  Yes 1.11 (0.95–1.29) NAe 1.07 (0.88–1.29)
 High-definition colonoscope
  No Reference Reference Reference NAf
  Yes 1.33 (1.17–1.50) NAf 1.13 (0.79–1.61)
  Unknown 2.01 (1.68–2.41) 0.87 (0.23–3.21) 1.00 (0.58–1.73)
 Withdrawal time
  <6 min Reference Reference Reference 0.55
  6–9 min 1.38 (0.83–2.32) 0.31 (0.05–1.83) 1.57 (0.54–4.53)
  >9 min 4.56 (2.57–8.12) 1.11 (0.48–2.54) 4.43 (1.26–15.59)
  Missing 3.80 (2.11–6.85) NA 2.45 (0.66–9.13)
 Preparation quality
  Adequate (excellent, good, or fair) Reference Reference Reference 0.03
  Inadequate (poor) 0.79 (0.53–1.18) 3.16 (0.92–10.80) 0.40 (0.14–1.19)
 Sedation type
  Moderate sedation Reference Reference Reference 0.75
  Other 0.90 (0.82–0.99) 0.83 (0.37–1.84) 0.95 (0.81–1.12)
Physician-related
 Endoscopist sex
  Male physician Reference Reference Reference 0.01
  Female physician 1.11 (0.89–1.39) 2.54 (1.21–5.33) 0.86 (0.64–1.16)
 Years in practice
  <11 yr Reference Reference Reference 0.002
  11–25 yr 0.89 (0.71–1.13) 4.36 (1.37–13.89) 0.99 (0.77–1.27)
  >25 yr 0.57 (0.30–1.08) 1.34 (0.31–5.86) 0.99 (0.82–1.20)

BMI, body mass index; CI, confidence interval; OR, odds ratio; SSADR, sessile serrated adenoma detection rate.

a

Multivariate model included variables for all patient-related, procedure-related, and physician-related characteristics and fixed effects of each year from 2010 to 2020.

b

Multivariate model in variables for all patient-related, procedure-related, and physician-related characteristics, except for mucosal assist device and high-definition colonoscope.

c

Multivariate model in variables for all patient-related, procedure-related, and physician-related characteristics.

d

P-interaction was calculated using cross product of year and with respective risk factor. Missing and unknown categories were omitted in the model to improve interpretability.

e

No mucosal assist device was used in 2010, so interaction was not calculated.

f

Interaction term was not calculated because OR did not converge for high-definition colonoscope in 2010.